Alkem Laboratories Management Change
Alkem Laboratories CFO Nitin Agrawal resigned effective 30 September 2026 for new opportunities. He was also a Key Managerial Personnel of the company.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Alkem Laboratories CFO Nitin Agrawal resigned effective 30 September 2026 for new opportunities. He was also a Key Managerial Personnel of the company.
Alkem Laboratories has appointed Dr. Shubhadeep Sinha as a Senior Management Personnel, effective September 15, 2026. This appointment falls under standard senior management disclosures.
Alkem Laboratories appointed Mr. Rajpal Singh Rana as Senior Vice President – Marketing & Sales, Acute Cluster, effective August 3, 2026.
Dr. Jitendra Singh Huda has resigned from his position as Senior Management Personnel. The resignation is effective from July 23, 2026.
Alkem Laboratories re-appointed Mrs. Madhurima Singh as Executive Director for a five-year term starting December 2026. This move ensures leadership continuity through 2031.
Alkem Laboratories appointed Mr. Chanakya Misra to a senior management position effective May 18, 2026. He brings over 25 years of pharmaceutical and healthcare experience.
Dr. Vikas Gupta has resigned as Chief Executive Officer of Alkem Laboratories Ltd to pursue new professional opportunities. He will continue in his role until June 30, 2026, to ensure a smooth transition of responsibilities.